RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) IN PATIENTS WITH BREAST-CANCERFOLLOWING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL (AHPC) SUPPORT
A. Hussein et al., RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) IN PATIENTS WITH BREAST-CANCERFOLLOWING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL (AHPC) SUPPORT, Experimental hematology, 24(9), 1996, pp. 634-634